Novel Turmeric Derivative Drug Shows Promise in Head and Neck Cancer

(MedPage Today) -- MONTREAL – An investigational drug derived from turmeric (Curcuma longa) appeared to have activity in patients being evaluated for head and neck cancer therapy, at least in an early phase trial. All nine oropharyngeal...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news